GO:0031595 nuclear proteasome complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031595 (nuclear proteasome complex) is defined as a proteasome found in the nucleus of a cell, distinguishing it from the more abundant cytoplasmic proteasome pool.
• Nuclear import of proteasomes is an active, signal-dependent process controlled by AKIRIN2 in vertebrates, which binds proteasome subunits and mediates their nuclear translocation.
• Nuclear proteasomes can undergo stress- and ubiquitylation-dependent phase separation, forming reversible condensates that modulate proteolytic activity.
• Nuclear proteasomes contribute to nuclear proteostasis and can buffer cytoplasmic proteins when autophagy is compromised, revealing crosstalk between nuclear and cytoplasmic degradation systems.
• Dysfunction of nuclear proteasome pathways has been linked to neurodegeneration, including Alzheimer's disease, and to cancer biology such as multiple myeloma.
• Studying GO:0031595 requires targeted methods such as knockout of import factors (e.g., AKIRIN2), tagged knock-in of proteasome subunits, and proteomics/imaging to resolve nuclear versus cytoplasmic pools.
Description
The nuclear proteasome complex (GO:0031595) is a cellular component defined as a proteasome found in the nucleus of a cell. Proteasomes are large, ATP-dependent proteolytic machines that degrade ubiquitylated proteins, and their presence in the nucleus allows for spatially restricted control of nuclear protein quality and regulatory turnover. While the cytoplasmic proteasome has been studied for decades, the nuclear pool has emerged as a distinct and functionally important entity that participates in nuclear proteostasis and gene regulation. Understanding GO:0031595 is therefore essential for researchers interested in how cells compartmentalize degradation and how this compartmentalization goes awry in disease. The nuclear proteasome is not simply a passive passenger of the cytoplasmic pool; its import is actively regulated, and its assembly and activity can be modulated by stress and ubiquitylation signals. This article summarizes the current, literature-supported understanding of the nuclear proteasome complex, its components, regulation, disease relevance, and the experimental methods used to study it.
nuclear proteasome complex At A Glance
| GO ID | GO:0031595 |
|---|---|
| GO term | nuclear proteasome complex |
| Ontology | cellular_component |
| Synonym | none listed in QuickGO |
| Major function | ATP-dependent degradation of ubiquitylated proteins within the nucleus, contributing to nuclear proteostasis and regulatory protein turnover |
| Subcellular location | Nucleus (nucleoplasm and nuclear-associated compartments) |
| Key import factor | AKIRIN2 mediates nuclear import of proteasomes in vertebrates |
| Regulatory feature | Stress- and ubiquitylation-dependent phase separation can modulate nuclear proteasome condensates |
| Disease relevance | Implicated in neurodegeneration (e.g., Alzheimer's disease) and cancer (e.g., multiple myeloma) |
What Is GO:0031595?
GO:0031595, nuclear proteasome complex, is a Gene Ontology cellular component term that refers to a proteasome localized to the nucleus of a cell. In practical terms, it denotes the 26S/30S proteasome holoenzyme and its subcomplexes when they are found inside the nuclear compartment, as opposed to the cytoplasm. The term captures the spatial context of proteasome function rather than a distinct catalytic mechanism, because the core proteolytic machinery is shared with cytoplasmic proteasomes.
Why Is nuclear proteasome complex Important in Cell Biology?
The nuclear proteasome complex matters because it provides a dedicated degradation system inside the nucleus, where many short-lived regulatory proteins, transcription factors, and damaged nuclear proteins must be turned over with spatial precision. Without nuclear proteasomes, cells would rely solely on cytoplasmic degradation, which is insufficient for nuclear proteostasis and for buffering proteotoxic stress when autophagy is compromised. Moreover, the nuclear proteasome is dynamically regulated by import factors and phase separation, making it a responsive hub that integrates stress signals with protein degradation. Its dysfunction has been linked to major human diseases, including Alzheimer's disease and multiple myeloma, underscoring its translational importance.
• Maintains nuclear proteostasis by degrading ubiquitylated nuclear proteins.
• Provides spatial control of regulatory protein turnover in the nucleus.
• Is actively imported into the nucleus via AKIRIN2 in vertebrates.
• Can form stress- and ubiquitylation-dependent phase-separated condensates.
• Buffers cytoplasmic proteins when autophagy is compromised.
• Is linked to neurodegeneration such as Alzheimer's disease.
• Is relevant to cancer biology, including multiple myeloma.
• Represents a target for targeted protein degradation strategies via direct 26S proteasome recruitment.
• Its dynamics differ from cytoplasmic proteasomes, requiring dedicated study.
• Offers opportunities for CRISPR-based functional dissection of import and assembly factors.
What Happens During nuclear proteasome complex?
Nuclear import of proteasomes
In simple terms: Proteasomes are built in the cytoplasm and then actively carried into the nucleus.
In vertebrates, the nuclear import of proteasomes is controlled by AKIRIN2, which binds proteasome subunits and mediates their translocation into the nucleus. This import step is essential for establishing the nuclear proteasome pool and distinguishes GO:0031595 from the cytoplasmic proteasome population. Loss of AKIRIN2 impairs nuclear proteasome import, demonstrating that nuclear localization is an active, regulated process rather than passive diffusion.
Stress- and ubiquitylation-dependent phase separation
In simple terms: Under stress, nuclear proteasomes can clump together into reversible droplets.
Nuclear proteasomes can undergo phase separation in a manner dependent on stress and ubiquitylation, forming condensates that modulate proteasome activity. This phase separation is reversible and provides a mechanism to concentrate proteasomes at specific nuclear sites under stress conditions. Such condensates are thought to influence substrate accessibility and degradation efficiency within the nucleus.
Nuclear proteostasis and buffering of cytoplasmic proteins
In simple terms: Nuclear proteasomes help clean up proteins in the nucleus and can even help when cytoplasmic cleanup is blocked.
Nuclear proteasomes contribute to the maintenance of nuclear proteostasis by degrading ubiquitylated nuclear proteins. When autophagy is compromised, nuclear proteasomes can buffer cytoplasmic proteins, revealing crosstalk between nuclear degradation and cytoplasmic quality control. This buffering capacity highlights the nuclear proteasome as a flexible component of the cellular proteostasis network.
Substrate recognition and degradation
In simple terms: Proteasomes recognize tagged proteins and cut them into small pieces.
Like cytoplasmic proteasomes, the nuclear proteasome recognizes ubiquitylated substrates and degrades them in an ATP-dependent manner. The 26S proteasome can be directly recruited to target proteins for degradation, as demonstrated by targeted degradation approaches. This substrate recognition mechanism is shared with cytoplasmic proteasomes, but its nuclear context allows for degradation of nuclear-specific substrates.
Key Genes Involved in GO:0031595 nuclear proteasome complex
The following genes and proteins are functionally linked to the nuclear proteasome complex (GO:0031595) based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AKIRIN2 | Mediates nuclear import of proteasomes in vertebrates | Knockout or knockdown to block nuclear proteasome import and study nuclear proteostasis |
| PSMD1 | 26S proteasome regulatory subunit; part of the proteasome holoenzyme | Tagged knock-in to track nuclear versus cytoplasmic proteasome pools |
| PSMD2 | 26S proteasome regulatory subunit; component of the 19S regulatory particle | Mutagenesis to study assembly and nuclear localization |
| PSMA1 | 20S proteasome alpha subunit; core catalytic particle | Overexpression or KO to assess nuclear proteasome assembly |
| PSMB5 | 20S proteasome beta subunit with chymotrypsin-like activity | Point mutation to alter catalytic activity and study nuclear substrates |
| PSMC2 | 19S regulatory particle ATPase; involved in substrate unfolding | Knockout to study ATP-dependent degradation in the nucleus |
| PSMC4 | 19S regulatory particle ATPase; part of the base complex | Tagged knock-in for imaging nuclear proteasome dynamics |
| UBB | Ubiquitin precursor; provides ubiquitin for substrate tagging | Overexpression to increase ubiquitylated nuclear substrates |
| UBC | Ubiquitin conjugating enzyme; involved in ubiquitylation | KO to reduce ubiquitylation and test nuclear proteasome dependence |
| SQSTM1 | Autophagy receptor; crosstalk with proteasome under autophagy compromise | KO to study nuclear proteasome buffering of cytoplasmic proteins |
| MAP1LC3B | Autophagy marker; used to monitor autophagy compromise | Knockout or reporter knock-in to induce autophagy stress |
| MIDN | Midnolin; mediates direct proteasome recruitment for degradation | KO or point mutation to study midnolin-proteasome pathway |
| PSMD14 | Deubiquitylating enzyme associated with the 19S particle | Point mutation to study substrate processing in the nucleus |
| ADRM1 | Proteasome-associated factor; involved in substrate recruitment | Knockout to assess nuclear substrate delivery |
| NGLY1 | Enzyme linked to proteasome-related stress pathways | KO to study proteostasis failure in neurodegeneration models |
| UBQLN2 | Ubiquitin-like protein implicated in proteostasis and neurodegeneration | Knock-in of disease mutations to model Alzheimer's-related proteostasis |
How Is nuclear proteasome complex Regulated?
The nuclear proteasome complex is regulated at multiple levels. Its nuclear import is controlled by AKIRIN2, which is required for vertebrate proteasome nuclear localization. Stress and ubiquitylation signals can trigger phase separation of nuclear proteasomes, dynamically modulating their activity and localization. Additionally, crosstalk with autophagy pathways influences nuclear proteasome function, as nuclear proteasomes can buffer cytoplasmic proteins when autophagy is compromised. These regulatory layers allow cells to adjust nuclear degradation capacity in response to changing conditions.
nuclear proteasome complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AKIRIN2 | Nuclear proteasome import defects | Knockout cell lines to block nuclear import |
| MIDN | Multiple myeloma suppression | Knockout or point mutation in myeloma cell lines |
| UBQLN2 | Alzheimer's disease and proteostasis failure | Knock-in of disease-associated mutations |
| SQSTM1 | Autophagy compromise and proteasome buffering | Knockout to induce autophagy stress |
| PSMB5 | Proteasome catalytic dysfunction | Point mutation to alter catalytic activity |
Neurodegeneration and Alzheimer's disease
Early proteasome downregulation and dysfunction contribute to proteostasis failure in Alzheimer's disease, implicating nuclear proteasome pathways in neurodegeneration. Dysfunction of nuclear ubiquitin-proteasome pathways can impair the clearance of damaged nuclear proteins, contributing to neuronal stress. Model systems that recapitulate proteasome dysfunction are valuable for studying these mechanisms.
Cancer and multiple myeloma
The midnolin-proteasome pathway plays a role in suppressing myeloma, linking nuclear proteasome biology to cancer. Targeted degradation via direct 26S proteasome recruitment is being explored as a therapeutic strategy in cancer. These findings suggest that nuclear proteasome components may be relevant to cancer cell survival and drug response.
Proteostasis and autophagy crosstalk
Nuclear proteasomes buffer cytoplasmic proteins during autophagy compromise, revealing a protective role in proteostasis. This crosstalk is relevant to diseases where autophagy is impaired, such as neurodegenerative disorders. Understanding this buffering capacity may inform therapeutic strategies that target nuclear proteasome function.
From nuclear proteasome complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of AKIRIN2 block nuclear proteasome import? | AKIRIN2 knockout cell line |
| How does stress affect nuclear proteasome phase separation? | Tagged knock-in of proteasome subunits with stress treatment |
| Can nuclear proteasomes buffer cytoplasmic proteins? | Autophagy-compromised cells with proteasome reporters |
| What is the role of midnolin in myeloma? | MIDN knockout or point mutation in myeloma cells |
| How does proteasome dysfunction contribute to Alzheimer's disease? | Knock-in of neurodegeneration-associated mutations |
| Can targeted degradation recruit nuclear proteasomes? | Overexpression of degron-tagged substrates |
How to Study the nuclear proteasome complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Subcellular fractionation + mass spectrometry | Nuclear versus cytoplasmic proteasome abundance and composition | Confirming nuclear localization of proteasome subunits |
| Fluorescence microscopy | Nuclear proteasome condensates and phase separation | Visualizing stress-induced phase separation |
| Degron reporter assays | Proteasome-dependent degradation activity | Measuring nuclear proteasome function |
| CRISPR knockout screens | Genes required for nuclear proteasome function | Identifying new regulators of nuclear import |
| Proximity labeling | Nuclear proteasome interactors | Mapping the nuclear proteasome interactome |
| Ubiquitin chain profiling | Substrate ubiquitylation status | Linking ubiquitylation to nuclear degradation |
| Live-cell imaging | Dynamic changes in nuclear proteasome localization | Tracking phase separation over time |
| Autophagy inhibition assays | Crosstalk between autophagy and nuclear proteasome | Testing buffering capacity |
Proteomics and subcellular fractionation
Subcellular fractionation followed by mass spectrometry can resolve nuclear versus cytoplasmic proteasome pools and identify nuclear-specific interactors. This approach is essential for confirming the localization of GO:0031595 components.
Imaging and phase separation assays
Fluorescence microscopy of tagged proteasome subunits allows visualization of nuclear proteasome condensates and their stress-dependent phase separation. Live-cell imaging can track dynamic changes in nuclear proteasome localization.
Functional degradation assays
Degradation assays using ubiquitylated substrates or degron reporters can measure nuclear proteasome activity. These assays help distinguish nuclear from cytoplasmic degradation contributions.
CRISPR-based genetic screens
CRISPR knockout screens can identify genes required for nuclear proteasome import, assembly, or function. Such screens are powerful for discovering new regulators of GO:0031595.
How CRISPR Can Be Used to Study GO:0031595 nuclear proteasome complex
Knockout
CRISPR knockout of AKIRIN2 or proteasome subunit genes can abolish nuclear proteasome import or assembly, enabling functional studies of GO:0031595. Knockout models are useful for testing whether nuclear proteostasis depends on specific components.
Point Mutation
Point mutations in catalytic subunits such as PSMB5 can selectively alter proteasome activity without eliminating the complex, allowing precise dissection of nuclear degradation. Such models help distinguish catalytic from structural roles.
Knock-in
Tagged knock-in of proteasome subunits (e.g., fluorescent tags) enables real-time imaging of nuclear proteasome localization and phase separation. Knock-in of disease-associated mutations can model proteostasis dysfunction.
Overexpression
Overexpression of degron-tagged substrates or proteasome components can enhance or perturb nuclear degradation, providing gain-of-function models. Overexpression of ubiquitin precursors can increase substrate load for nuclear proteasomes.
How EDITGENE Supports nuclear proteasome complex Research
Researchers studying nuclear proteasome complex-related genes often need to determine whether a candidate gene is causally involved in nuclear proteostasis, import, or assembly. CRISPR-based models provide a rigorous way to test these hypotheses by precisely manipulating genes such as AKIRIN2, PSMB5, or MIDN in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for nuclear proteasome complex research.
Frequently Asked Questions About nuclear proteasome complex
What is GO:0031595 nuclear proteasome complex?
GO:0031595 is a Gene Ontology cellular component term defined as a proteasome found in the nucleus of a cell, distinct from cytoplasmic proteasomes.
What genes are involved in nuclear proteasome complex?
Key genes include AKIRIN2, which mediates nuclear import, and proteasome subunits such as PSMB5 and PSMD1.
How is the nuclear proteasome imported into the nucleus?
In vertebrates, AKIRIN2 binds proteasome subunits and mediates their nuclear import.
What is the role of phase separation in nuclear proteasomes?
Nuclear proteasomes can undergo stress- and ubiquitylation-dependent phase separation, forming reversible condensates that modulate activity.
Is the nuclear proteasome linked to Alzheimer's disease?
Yes, early proteasome downregulation and dysfunction contribute to proteostasis failure in Alzheimer's disease.
How does the nuclear proteasome relate to cancer?
The midnolin-proteasome pathway plays a role in suppressing myeloma, linking nuclear proteasome biology to cancer.
Can nuclear proteasomes buffer cytoplasmic proteins?
Yes, nuclear proteasomes can buffer cytoplasmic proteins when autophagy is compromised.
What methods are used to study nuclear proteasomes?
Subcellular fractionation, mass spectrometry, fluorescence imaging, and CRISPR screens are commonly used.
What is the difference between nuclear and cytoplasmic proteasomes?
They share catalytic machinery but differ in localization and regulation, with nuclear import controlled by AKIRIN2.
How can CRISPR help study nuclear proteasome complex?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise dissection of nuclear proteasome function.
Conclusion
The nuclear proteasome complex (GO:0031595) is a distinct and functionally important cellular component that supports nuclear proteostasis and integrates stress signals through regulated import and phase separation. Its dysfunction is linked to neurodegeneration and cancer, making it a compelling target for mechanistic and translational research. CRISPR-based models and advanced proteomic and imaging methods provide powerful tools to dissect its components, regulation, and disease relevance.
References
- 1. de Almeida M et al.. 2021. AKIRIN2 controls the nuclear import of proteasomes in vertebrates.. Nature 599(7885):491-496 PMID: 34711951
- 2. Yasuda S et al.. 2020. Stress- and ubiquitylation-dependent phase separation of the proteasome.. Nature 578(7794):296-300 PMID: 32025036
- 3. Franić D et al.. 2021. Nuclear Ubiquitin-Proteasome Pathways in Proteostasis Maintenance.. Biomolecules 11(1) PMID: 33406777
- 4. Jiang S et al.. 2025. Early proteasome downregulation and dysfunction drive proteostasis failure in Alzheimer's disease.. Brain 148(12):4372-4388 PMID: 40488453
- 5. Nardone C et al.. 2025. Structural basis for the midnolin-proteasome pathway and its role in suppressing myeloma.. Mol Cell 85(13):2597-2609.e11 PMID: 40532701
- 6. Park SJ et al.. 2024. Nuclear proteasomes buffer cytoplasmic proteins during autophagy compromise.. Nat Cell Biol 26(10):1691-1699 PMID: 39209961
- 7. Bashore C et al.. 2023. Targeted degradation via direct 26S proteasome recruitment.. Nat Chem Biol 19(1):55-63 PMID: 36577875
- 8. Enenkel C. 2014. Proteasome dynamics.. Biochim Biophys Acta 1843(1):39-46 PMID: 23545412
